| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1107084281 |
| P356 | DOI | 10.1038/S41398-018-0245-0 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41398-018-0245-0 |
| P932 | PMC publication ID | 6145889 |
| P698 | PubMed publication ID | 30232320 |
| P50 | author | Jian-Jun Chen | Q89628907 |
| P2093 | author name string | Peng Xie | |
| Liang Fang | |||
| Peng Zheng | |||
| Wen-Wen Li | |||
| Hai-Yang Wang | |||
| Chan-Juan Zhou | |||
| Shun-Jie Bai | |||
| Yi-Yun Liu | |||
| P2860 | cites work | The human urine metabolome | Q21132532 |
| Melatonin for pre- and postoperative anxiety in adults | Q24186566 | ||
| The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care | Q24682953 | ||
| Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches | Q26770334 | ||
| The assessment of anxiety states by rating | Q29614719 | ||
| Analysis of metabolomic data using support vector machines | Q33366103 | ||
| Epidemiology of mental disorders in children and adolescents. | Q33595270 | ||
| Novel urinary metabolite signature for diagnosing postpartum depression | Q33704082 | ||
| Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking | Q33897377 | ||
| Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence | Q33974684 | ||
| Aminomalonic acid: identification in Escherichia coli and atherosclerotic plaque | Q34257368 | ||
| Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). | Q51941445 | ||
| Mental disorders and disability among patients in a primary care group practice. | Q51997859 | ||
| Suicide attempts in patients with panic disorder. | Q52273432 | ||
| Sex differences in gut microbiota in patients with major depressive disorder. | Q52665670 | ||
| A structured interview version of the Hamilton Depression Rating Scale: evidence of reliability and versatility of administration. | Q52864890 | ||
| Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors: a longitudinal, population-based study. | Q52922033 | ||
| Major Depressive Disorder | Q56016676 | ||
| Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model Hepatotoxins | Q58046285 | ||
| Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders | Q71590808 | ||
| A multi-analytical platform approach to the metabonomic analysis of plasma from normal and Zucker (fa/fa) obese rats | Q80037913 | ||
| Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization | Q80240740 | ||
| Metabolomics: a global biochemical approach to drug response and disease | Q34734298 | ||
| Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients | Q35645024 | ||
| Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder | Q36400018 | ||
| The incidence of alkaptonuria: a study in chemical individuality. 1902. | Q36437917 | ||
| Potential metabolite markers of schizophrenia. | Q36479055 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Metabonomics study of essential hypertension and its chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy | Q36682631 | ||
| End-product regulation of the tryptophan-nicotinic acid pathway in Neurospora crassa | Q36773311 | ||
| Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel. | Q36936018 | ||
| Co-morbidity between major depressive disorder and anxiety disorders: shared etiology or direct causation? | Q37020611 | ||
| Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics | Q37648213 | ||
| Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. | Q37733240 | ||
| Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure | Q38461141 | ||
| Anxiety and Depression as Bidirectional Risk Factors for One Another: A Meta-Analysis of Longitudinal Studies | Q38626263 | ||
| Differential urinary metabolites related with the severity of major depressive disorder | Q38669894 | ||
| Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach | Q38985361 | ||
| Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. | Q39017815 | ||
| Aminomalonic Acid and Its Congeners as Potential in vivo Inhibitors of L-Asparagine Synthetase | Q39247481 | ||
| Anxiety and depression in older patients: the role of culture and acculturation | Q42278981 | ||
| Neuroticism as a common feature of the depressive and anxiety disorders: a test of the revised integrative hierarchical model in a national sample | Q42680972 | ||
| Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls | Q43119044 | ||
| Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups. | Q43187905 | ||
| A novel urinary metabolite signature for diagnosing major depressive disorder | Q43827823 | ||
| Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study | Q44300558 | ||
| Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. | Q44315060 | ||
| Clinical diagnosis of depression in primary care: a meta-analysis | Q44323103 | ||
| Childhood life events and childhood trauma in adult patients with depressive, anxiety and comorbid disorders vs. controls | Q44848084 | ||
| Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). | Q44957948 | ||
| Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. | Q45222765 | ||
| Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. | Q46478771 | ||
| Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | Q46565524 | ||
| Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression | Q48220933 | ||
| Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. | Q48593700 | ||
| Plasma amino acid levels discriminate between control subjects and mildly depressed elderly women. | Q48631302 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| biological psychiatry | Q2706176 | ||
| P304 | page(s) | 192 | |
| P577 | publication date | 2018-09-19 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Urinary biomarker panel for diagnosing patients with depression and anxiety disorders | |
| P478 | volume | 8 |
| Q89628910 | Age-specific differential changes on gut microbiota composition in patients with major depressive disorder |
| Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder |
| Q59809178 | Carbon Dioxide Laser Microsurgery versus Low-Temperature Plasma Radiofrequency Ablation for T1a Glottic Cancer: A Single-Blind Randomized Clinical Trial |
| Q90371599 | Circulating microRNA 134 sheds light on the diagnosis of major depressive disorder |
| Q59135098 | Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo |
| Q90353598 | Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression |
| Q90781303 | Hippocampal proteomic changes of susceptibility and resilience to depression or anxiety in a rat model of chronic mild stress |
| Q99403576 | Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics |
| Q90471425 | Identification of metabolite biomarkers in serum of rats exposed to chlorpyrifos and cadmium |
| Q64104741 | Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus |
| Q93185341 | Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus |
| Q64262134 | Urinary metabolite signature in bipolar disorder patients during depressive episode |
Search more.